ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 662,30
-0,58%
Dow Jones
39 112,16
-0,76%
DAX
18 177,62
-0,90%
Brent Oil
84,455
0,32%
Bitcoin
62 217,60
0,67%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Shuttle Pharmaceuticals Holdings Inc (SHPH)

  7. Shuttle Pharmaceuticals Holdings Inc (SHPH) Actualités

SHPH Shuttle Pharmaceuticals Holdings Inc

0,3949
0,01165 (3,04%)
25 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Shuttle Pharmaceuticals Holdings Inc SHPH NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,01165 3,04% 0,3949 23:48:20
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,362 0,362 0,3999 0,393 0,38325
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
18/6/202415:00EDGAR2Form 8-K - Current report
18/6/202415:00GLOBEShuttle Pharma Appoints Timothy Lorber as Chief Financial..
10/6/202412:12EDGAR2Form PRE 14A - Other preliminary proxy statements
22/5/202422:15EDGAR2Form 8-K - Current report
22/5/202422:15GLOBEShuttle Pharma to Participate in the Lytham Partners Spring..
14/5/202415:00EDGAR2Form 8-K - Current report
14/5/202415:00GLOBEShuttle Pharma Provides First Quarter 2024 Corporate Update
13/5/202423:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
23/4/202422:15GLOBEShuttle Pharmaceuticals to Present at the Planet MicroCap..
22/3/202414:00PRNUSShuttle Pharma Provides Fourth Quarter 2023 Corporate Update
09/3/202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:00EDGAR2Form 8-K - Current report
13/2/202414:00EDGAR2Form 8-K - Current report
13/2/202414:00PRNUSShuttle Pharma Announces Its Intent to Pursue a Rights..
05/2/202422:25EDGAR2Form 8-K - Current report
23/1/202422:30PRNUSShuttle Pharma to Participate in a Fireside Chat at the..
08/1/202415:05EDGAR2Form 8-K - Current report
08/1/202415:00PRNUSShuttle Pharmaceuticals Receives FDA Approval to Proceed..
02/1/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202303:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202323:10EDGAR2Form 8-K - Current report
11/12/202315:00EDGAR2Form 8-K - Current report
11/12/202315:00PRNUSShuttle Pharmaceuticals Submits IND Application to the U.S...
30/11/202315:00EDGAR2Form 8-K - Current report
14/11/202315:00PRNUSShuttle Pharmaceuticals Provides Third Quarter 2023..
13/11/202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202314:00PRNUSShuttle Pharma Advances Prostate Cancer Predictive Biomarker..
30/10/202322:14EDGAR2Form 8-K - Current report
20/10/202322:15EDGAR2Form ARS - Annual Report to Security Holders
20/10/202322:10EDGAR2Form DEF 14A - Other definitive proxy statements
10/10/202315:00EDGAR2Form 8-K - Current report
10/10/202315:00PRNUSShuttle Pharma to Participate in the Lytham Partners Fall..
05/10/202322:10EDGAR2Form 8-K - Current report
25/9/202315:00EDGAR2Form 8-K - Current report
25/9/202315:00PRNUSShuttle Pharma Announces Results of Pre-IND Meeting with FDA..
13/9/202315:00PRNUSShuttle Pharma Participates in Hampton University Proton..
11/9/202315:00PRNUSShuttle Pharma Expands Patent Coverage on HDAC Inhibitor..
07/9/202315:20EDGAR2Form 8-K - Current report
29/8/202315:00PRNUSShuttle Pharma's Selective HDAC6 Inhibitor Shown to..
24/8/202320:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/8/202301:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202315:00EDGAR2Form 8-K - Current report
15/8/202315:00PRNUSShuttle Pharmaceuticals Provides Second Quarter 2023..
14/8/202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202315:00EDGAR2Form 8-K - Current report
03/8/202315:00PRNUSShuttle Pharmaceuticals Completes Manufacturing of Active..

Dernières Valeurs Consultées

NASDAQ
SHPH
Shuttle Pharmaceuticals
TG
2CP
Capital Power
USOTC
EEENF
88 Energy (PK)
EU
MNEMO
BPCE Bpcefrn14dec28
LSE
COTN
Wt Cotton
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés